DSpace university logo mark
Advanced Search
Japanese | English 

NAOSITE : Nagasaki University's Academic Output SITE > Graduate School of Biomedical Sciences > Articles in academic journal >

A novel role of serum cytochrome c as a tumor marker in patients with operable cancer.


File Description SizeFormat
JCRCO135_371.pdf413.04 kBAdobe PDFView/Open

Title: A novel role of serum cytochrome c as a tumor marker in patients with operable cancer.
Authors: Osaka, Akemi / Hasegawa, Hiroo / Yamada, Yasuaki / Yanagihara, Katsunori / Hayashi, Tomayoshi / Mine, Mariko / Aoyama, Muneo / Sawada, Takashi / Kamihira, Shimeru
Issue Date: Mar-2009
Publisher: Springer Berlin
Citation: Journal of cancer research and clinical oncology, 135(3), pp.371-377; 2009
Abstract: PURPOSE: This study aimed to evaluate serum cytochrome c (cyto-c) levels as a novel role of tumor marker in patients with operable malignant tumors. METHODS: Serum cyto-c levels and lactate dehydrogenase (LD) activity were measured in a total of 257 cases (232 malignant and 25 benign). To identify the relationship between serum cyto-c and current tumor markers, six variables, such as gender, age, invasion, lymph node metastasis, distant metastasis, and LD, were analyzed by uni- and multivariate regression analysis methods. The test performance of serum cyto-c for the prediction of malignant behavior was evaluated by receiver operating characteristic (ROC) curves. RESULTS: The serum cyto-c level was significantly higher in patients with malignant tumors than patients with benign tumors (20.6 vs. 15.5 ng/mL; P = 0.017, Mann-Whitney U test). No difference in the levels among subtypes of cancer was found, indicating that the change in serum cyto-c levels reflect cancer individually and not specific subtypes of cancer. The survival in patients with serum cyto-c levels over 40 ng/mL was poor (Kaplan-Meier test, P < 0.0001, Hazard ratio 16.76, 95% confidential interval 4.45-63.04). Multiple linear regression analyses disclosed the close association of serum cyto-c levels with invasion (P = 0.0004), metastasis (P = 0.0262) except for regional lymph node metastasis, and activity of serum LD (P < 0.0001), all of which are well known to represent malignant behavior. Conversely, the measurement of serum cyto-c was verified to have excellent diagnostic accuracy of 0.802 and 0.781 for the detection of invasion and metastasis (the area under curves of the constructed ROCs). CONCLUSION: Serum cyto-c is a potent tumor marker as a predictor for malignant potential in cancers.
Keywords: Cytochrome c / Metastatic potential / Prediction / Tumor marker
URI: http://hdl.handle.net/10069/22278
ISSN: 01715216
DOI: 10.1007/s00432-008-0479-y
PubMed ID: 18825408
Rights: © Springer-Verlag 2008 / The original publication is available at www.springerlink.com
Type: Journal Article
Text Version: author
Appears in Collections:Articles in academic journal

Citable URI : http://hdl.handle.net/10069/22278

All items in NAOSITE are protected by copyright, with all rights reserved.

 

Valid XHTML 1.0! Copyright © 2006-2015 Nagasaki University Library - Feedback Powerd by DSpace